
| Phytochemical Name | Chebulagic acid |
| PubChem CID | 250397 |
| Disease Indication | Antiviral [ICD-11: 1D9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Doxorubicin |
| Source |
Warm
Syzygium aromaticum ;
Terminalia chebula;
Piperbetle;
Even
Terminalia chebula
|
| Phytochemical Name | Chebulagic acid |
| PubChem CID | 250397 |
| Disease Indication | Antiviral [ICD-11: 1D9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Doxorubicin |
| Source |
Warm
Syzygium aromaticum ;
Terminalia chebula;
Piperbetle;
Even
Terminalia chebula
|
| Phytochemical Name | Eugenol |
| PubChem CID | 3314 |
| Disease Indication | Necrotic primary molars [ICD-11: DA09] Phase 4 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: 2-methoxyestradiol; Cisplatin; Fluorouracil; Gemcitabine; Sorafenib |
| Source |
Warm
Syzygium aromaticum
|
| Phytochemical Name | Chebulagic acid |
| PubChem CID | 250397 |
| Disease Indication | Antiviral [ICD-11: 1D9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Doxorubicin |
| Source |
Warm
Syzygium aromaticum ;
Terminalia chebula;
Piperbetle;
Even
Terminalia chebula
|
| Phytochemical Name | Chebulagic acid |
| PubChem CID | 250397 |
| Disease Indication | Antiviral [ICD-11: 1D9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Doxorubicin |
| Source |
Warm
Syzygium aromaticum ;
Terminalia chebula;
Piperbetle;
Even
Terminalia chebula
|
| Phytochemical Name | Piceatannol |
| PubChem CID | 667639 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Everolimus; Gemcitabine; Shikonin |
| Source |
Even
Rhodomyrtus tomentosa
Cold
Polygonum cuspidatum;
|
| Phytochemical Name | Eugenol |
| PubChem CID | 3314 |
| Disease Indication | Necrotic primary molars [ICD-11: DA09] Phase 4 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: 2-methoxyestradiol; Cisplatin; Fluorouracil; Gemcitabine; Sorafenib |
| Source |
Warm
Syzygium aromaticum
|
| Phytochemical Name | Evening primrose oil |
| Disease Indication | Breast cancer [ICD-11: 2C60] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Tamoxifen |
| Source |
Warm
Oenothera biennis
|